Literature DB >> 5763976

Amino acid levels following L-asparagine amidohydrolase (EC.3.5.1.1) therapy.

H K Miller, J S Salser, M E Balis.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1969        PMID： 5763976

Source DB:  PubMed          Journal:  Cancer Res        ISSN： 0008-5472            Impact factor:   12.701


× No keyword cloud information.
  16 in total

Review 1.  Molecular pharmacodynamics in childhood leukemia.

Authors:  R Pieters; M L den Boer
Journal:  Int J Hematol       Date:  2003-12       Impact factor: 2.490

2.  Inhibiting glutamine uptake represents an attractive new strategy for treating acute myeloid leukemia.

Authors:  Lise Willems; Nathalie Jacque; Arnaud Jacquel; Nathalie Neveux; Thiago Trovati Maciel; Mireille Lambert; Alain Schmitt; Laury Poulain; Alexa S Green; Madalina Uzunov; Olivier Kosmider; Isabelle Radford-Weiss; Ivan Cruz Moura; Patrick Auberger; Norbert Ifrah; Valérie Bardet; Nicolas Chapuis; Catherine Lacombe; Patrick Mayeux; Jérôme Tamburini; Didier Bouscary
Journal:  Blood       Date:  2013-09-06       Impact factor: 22.113

Review 3.  Antineoplastic and immunosuppressive drugs. I. Biochemical and clinical pharmacological considerations.

Authors:  A H Chalmers; L A Burgoyne; A W Murray
Journal:  Drugs       Date:  1972       Impact factor: 9.546

Review 4.  Amino acid metabolism in hematologic malignancies and the era of targeted therapy.

Authors:  Yoko Tabe; Philip L Lorenzi; Marina Konopleva
Journal:  Blood       Date:  2019-08-15       Impact factor: 22.113

5.  Multiple adaptive mechanisms affect asparagine synthetase substrate availability in asparaginase-resistant MOLT-4 human leukaemia cells.

Authors:  A M Aslanian; M S Kilberg
Journal:  Biochem J       Date:  2001-08-15       Impact factor: 3.857

6.  Asparagine synthetase is partially localized to the plasma membrane and upregulated by L-asparaginase in U937 cells.

Authors:  Yingyi He; Benshang Li; Changying Luo; Shuhong Shen; Jing Chen; Huiliang Xue; Jingyan Tang; Longjun Gu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2011-04-20

Review 7.  L-asparaginase treatment in acute lymphoblastic leukemia: a focus on Erwinia asparaginase.

Authors:  Rob Pieters; Stephen P Hunger; Joachim Boos; Carmelo Rizzari; Lewis Silverman; Andre Baruchel; Nicola Goekbuget; Martin Schrappe; Ching-Hon Pui
Journal:  Cancer       Date:  2010-09-07       Impact factor: 6.860

8.  Pharmacokinetics of PEG-L-asparaginase and plasma and cerebrospinal fluid L-asparagine concentrations in the rhesus monkey.

Authors:  S L Berg; F M Balis; C L McCully; K S Godwin; D G Poplack
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

9.  Immunological responses to L-asparaginase.

Authors:  R G Peterson; R E Handschumacher; M S Mitchell
Journal:  J Clin Invest       Date:  1971-05       Impact factor: 14.808

10.  Pharmacological inhibition of fatty-acid oxidation synergistically enhances the effect of l-asparaginase in childhood ALL cells.

Authors:  I Hermanova; A Arruabarrena-Aristorena; K Valis; H Nuskova; M Alberich-Jorda; K Fiser; S Fernandez-Ruiz; D Kavan; A Pecinova; M Niso-Santano; M Zaliova; P Novak; J Houstek; T Mracek; G Kroemer; A Carracedo; J Trka; J Starkova
Journal:  Leukemia       Date:  2015-08-04       Impact factor: 11.528
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.